Blog
 » 
Infection
 » 
Can MRSP or MRSA Occur After TPLO Surgery?

Can MRSP or MRSA Occur After TPLO Surgery?

Infection

X min read

Owners

Learn whether MRSP or MRSA can occur after TPLO surgery in dogs, how these resistant infections develop, warning signs, and treatment challenges.

By 

Sustainable Vet Group

Updated on

August 3, 2026

.

This article is for informational purposes only and is not a substitute for professional veterinary advice. Every case is unique, so always consult your veterinarian for guidance specific to your pet.

This content is intended for veterinary professionals for educational purposes. It does not replace clinical judgment or tailored advice. Always rely on your training, expertise, and the specific context of your patients.

Can MRSP or MRSA Occur After TPLO Surgery?

Yes, both MRSP (methicillin-resistant Staphylococcus pseudintermedius) and MRSA (methicillin-resistant Staphylococcus aureus) can occur as TPLO surgical site infections.

They are not the same organism, differ in their origin and prevalence in dogs, and require different management considerations.

MRSP is by far the more common of the two in canine TPLO infections.

 

Quick answer: Yes, both MRSP and MRSA can occur after TPLO surgery. MRSP is more common; 4.4% of TPLO dogs carry MRSP pre-operatively and carriage increases SSI risk 6.7-fold. MDR staphylococci occur in 20 to 40% of isolates. Both require culture-directed treatment.

 

Key takeaways

  • MRSP is far more common than MRSA in canine TPLO infections: S. pseudintermedius is the predominant dog skin commensal; MRSP dominates among resistant strains in dogs
  • 4.4% of TPLO dogs carry MRSP pre-operatively: PubMed data from 549 dogs; carriage increases SSI risk OR 6.72 (95% CI 2.12 to 21.4)
  • MRSA in dogs typically originates from human contact: S. aureus is primarily a human commensal; MRSA in dogs usually reflects human-to-dog transmission
  • Standard cefazolin prophylaxis does not cover MRSP or MRSA: the mecA gene produces PBP2a, rendering all beta-lactam antibiotics ineffective
  • Treatment requires culture and sensitivity testing: MRSP options are limited to rifampin combinations, chloramphenicol, minocycline, and linezolid depending on susceptibility
  • MRSA carries zoonotic risk to household members: MRSA is transmissible between dogs and people; handwashing and wound coverage significantly reduce transmission risk

MRSP: the dominant resistant pathogen in canine TPLO

What MRSP is

MRSP is the methicillin-resistant form of Staphylococcus pseudintermedius.

It carries the mecA gene, which encodes PBP2a (penicillin-binding protein 2a), a modified enzyme that prevents beta-lactam antibiotics from binding to the bacterial cell wall.

This single gene change confers resistance to:

  • All penicillins (amoxicillin, amoxicillin-clavulanate, ampicillin)
  • All cephalosporins (cephalexin, cefpodoxime, cefazolin)
  • All carbapenems (imipenem, meropenem)
  • Often also: fluoroquinolones, clindamycin, tetracyclines, and trimethoprim-sulfamethoxazole

DVM360 confirms: treatment of canine pyoderma and other infections has been made more difficult by the emergence of MRSP. MRSP infections require culture-guided treatment from a narrow effective range.

SustainableVet.org confirms: MRSP carries the mecA gene, which produces PBP2a that prevents beta-lactam antibiotics from binding.

How common is MRSP in TPLO?

PubMed study (549 TPLO dogs): 4.4% were MRSP carriers pre-operatively. MRSP was isolated from 34% of culture-confirmed SSIs. Pre-operative MRSP carriage was a significant risk factor (OR 6.72) for SSI after TPLO.

PMC 769-TPLO study: 35.1% of S. pseudintermedius isolates from TPLO SSI cases were MDR.

Literature review cited in PMC: 20 to 40% of staphylococcal isolates from dogs with SSI after TPLO are multidrug-resistant.

SustainableVet.org confirms: MRSP is the methicillin-resistant form of S. pseudintermedius, the most common bacteria on dog skin; its resistance makes it a significant concern in post-surgical wound management.

MRSP treatment for TPLO infections

MRSP eliminates the standard first-line antibiotic options. Treatment choices depend entirely on susceptibility testing results. Agents that may be effective include:

  • Rifampin (rifampicin): highly active against staphylococcal biofilm when used in combination; never used as monotherapy because resistance emerges rapidly
  • Chloramphenicol: effective against many MRSP strains; requires owner precautions (gloves when handling) due to potential for aplastic anemia in humans
  • Minocycline or doxycycline: often effective depending on susceptibility
  • Linezolid: reserved for severe cases; expensive and associated with bone marrow suppression with long-term use
  • Combination therapy: rifampin combined with a second susceptible agent is the most effective approach for biofilm-associated MRSP infections

If the TPLO plate is involved (biofilm on the implant surface), antibiotics alone are insufficient. Plate removal combined with appropriate antibiotic therapy is required for definitive cure.

MRSA: the human-origin resistant pathogen in TPLO

What MRSA is

MRSA is the methicillin-resistant form of Staphylococcus aureus. It carries the same mecA gene mechanism as MRSP, conferring resistance to all beta-lactams.

S. aureus is primarily a human commensal. MRSA in dogs most commonly reflects transmission from a human carrier in the household or from a clinical environment where the dog has been hospitalized.

This bidirectional transmission (humans infecting dogs, dogs potentially reinfecting humans) makes MRSA a genuine zoonotic concern in TPLO cases.

SustainableVet.org confirms: MRSA in dogs usually originates from humans and can infect dogs through close contact, particularly in households or clinical settings.

MRSP is adapted to dogs and is far more prevalent in the canine population.

How common is MRSA in TPLO?

PMC 769-TPLO study: S. aureus (n=10) was the second most common TPLO SSI isolate; 50% of those were MDR (likely MRSA).

PMC case report (Open Veterinary Journal, 2021): describes an MRSA TPLO infection in a 7-year-old female American cocker spaniel that developed after the dog licked the incision.

The case was treated with vancomycin and rifampicin. This is the first reported MRSA TPLO case in published literature.

The PMC case confirms: the direct cause of wound contamination was licking of the surgical site, introducing MRSA presumably from human household contact.

MRSA treatment for TPLO infections

MRSA in dogs may be susceptible to chloramphenicol, minocycline, doxycycline, or rifampin combinations similar to MRSP depending on the specific isolate's susceptibility profile.

In severe cases, vancomycin may be required as confirmed in the PMC case report.

The PMC case used vancomycin (10 mg/kg IV every 8 hours) and rifampicin (10 mg/kg orally twice daily). This combination was selected based on sensitivity testing.

Zoonotic risk: MRSA from dog to human

MRSA is a recognized zoonotic pathogen.

A dog with MRSA TPLO infection poses a potential (though low) transmission risk to household members, particularly those who are immunocompromised, elderly, very young, or have skin breaks.

Recommended precautions:

  • Handwash thoroughly with soap and water after any contact with the wound or discharge
  • Wear disposable gloves when handling wound dressings
  • Keep the wound covered when possible
  • Avoid allowing the dog to lick human skin or faces
  • Launder the dog's bedding separately at 60 degrees or higher

MRSP is primarily a veterinary pathogen with limited transmission to humans in normal circumstances. Immunocompromised household members should discuss MRSP exposure with their physician.

Diagnosing MRSP and MRSA after TPLO

Neither MRSP nor MRSA can be identified clinically they look identical to methicillin-susceptible staphylococci on wound examination. Diagnosis requires:

  1. Bacterial culture with species-level identification
  2. Methicillin susceptibility testing (oxacillin disk or mecA PCR)
  3. Full antibiotic susceptibility panel against all relevant antibiotic classes

Swabs of wound discharge should be taken before any antibiotic therapy is started. Tissue biopsies or aspirates from deep infections provide more representative samples than surface swabs.

For the antibiotic treatment guide, see what antibiotics are commonly used for TPLO infections. For the broader bacteria guide, see what bacteria commonly cause TPLO infections?.

For the staph infection overview, see is staph the most common infection after TPLO surgery?. For the culture timing guide, see when should a culture be taken for suspected TPLO infection?.

Frequently asked questions

How do I know if my dog has MRSP or regular staph after TPLO?

You cannot tell clinically. The wound signs (redness, discharge, pain, lameness) are identical regardless of methicillin resistance status. Culture with susceptibility testing is the only way to confirm MRSP or MRSA.

An infection that fails to improve on first-line antibiotics (amoxicillin-clavulanate, cephalexin) is a clinical signal that resistance is present.

Can my dog have MRSP before TPLO surgery without showing any signs?

Yes. Pre-operative MRSP carriage is asymptomatic in most dogs. PubMed data confirms 4.4% of TPLO dogs carry MRSP on their skin before surgery without any clinical infection signs.

These carriers are identified only by pre-operative skin swab culture if this is performed.

Should my dog be screened for MRSP before TPLO?

Pre-operative MRSP screening is not universally recommended in standard practice, but it is performed at some referral centers where MRSP SSI rates are a concern.

If your dog has a history of MRSP infections or has had previous TPLO surgery at a facility with a known MRSP cluster, discuss pre-operative screening with your surgeon.

Is an MRSP TPLO infection curable?

Yes, with appropriate treatment. Most MRSP TPLO infections resolve with culture-directed antibiotic therapy, strict wound management, and plate removal if the implant is involved.

The treatment is more complex and takes longer than methicillin-susceptible infections, but the prognosis is good when managed correctly.

Does my dog need to be isolated from other dogs if it has MRSP?

Standard household isolation is not routinely required, but contact between the infected wound and other dogs or people should be minimized. Do not allow other dogs to lick the wound.

The primary concern is preventing wound-to-wound or wound-to-skin transmission within the household.

Resources

  • PubMed. Association Between MRSP Carriage and SSI Following TPLO in Dogs. pubmed.ncbi.nlm.nih.gov
  • PMC. Treatment of MRSA Infection Following TPLO in a Dog. pmc.ncbi.nlm.nih.gov
  • DVM360. The Emergence and Prevalence of MRSA, MRSP, and MRSS in Pets and People. dvm360.com
  • PMC. Surgical Site Infection After 769 Tibial Plateau Leveling Osteotomies. pmc.ncbi.nlm.nih.gov
  • VCA Animal Hospitals. Tibial Plateau Leveling Osteotomy (TPLO) in Dogs. vcahospitals.com

Get a Free Poster

Enhance your workspace with a high-quality radiographs reference poster, designed for veterinary professionals. This free physical poster will be shipped directly to you—just fill out the form to request your copy.

Things to know

Get a Free Poster for Your Clinic

Enhance your workspace with a high-quality radiographs reference poster, designed for veterinary professionals. This free physical poster will be shipped directly to you—just fill out the form to request your copy.

We'd love you to
Join Us!

Enter Your Details Below to Receive Your Information Pack

100% safe & secure. Your details are never shared or sold.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Taking Great TPLO Radiographs

Click Below to Watch Live Video Demos

We'll send you a Free Wall Poster with all the steps

Now that you are a pro at TPLO rads

Let's take your infection control to the next level

Watch these videos!

Step #1

Getting Ready

Ensuring a clean surgical field starts with proper skin preparation. This video demonstrates the best practices for:

  • Shaving the patient – Achieving a close, even shave while minimizing skin irritation
  • The Dirty Scrub – The initial skin prep step to remove surface debris and reduce bacterial load before the sterile scrub.

Following these techniques helps reduce infection risk and improve surgical outcomes. Watch the video to see how it’s done effectively!

Step #2

Reduce Your Risks

Many surgeons are shocked to find out that their patients are not protected from biofilms and resistant bacteria when they use saline and post-op antibiotics.

That’s Where Simini Comes In.

Why leave these risks and unmanaged?  Just apply Simini Protect Lavage for one minute. Biofilms and resistant bacteria can be removed, and you can reduce two significant sources of infection.

Step #3

Take the Course

Preventing surgical infections is critical for patient safety and successful outcomes. This course covers:

  • Aseptic techniques – Best practices to maintain a sterile field.
  • ​Skin prep & draping – Proper methods to minimize contamination.
  • ​Antibiotic stewardship – When and how to use perioperative antibiotics effectively.

Stay up to date with the latest evidence-based protocols. Click the link to start learning and earn CE credits!

Get Your
Free Poster!

Enter your information below, and we’ll ship it to you at no cost.

Do you want to customize it?

How many would you like?

About you

Shipping information

100% safe & secure. Your details are never shared or sold.

We will work on your request shortly.
Oops! Something went wrong while submitting the form.
What’s your role in animal care?

Tell us who you are so we can guide you to the most relevant information.